Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check3 days agoChange DetectedThe page reflects small non-study informational updates, including resource/glossary labeling and a software/version revision change from v3.5.2 to v3.5.3. No substantive changes to the trial’s core study content (like eligibility criteria, interventions, or outcome measures) are indicated.SummaryDifference0.2%

- Check10 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRemoved non-core items: the term 'Interstitial lung disease 2' and the Genetics and Rare Diseases Information Center resource link. These deletions do not affect the study's main data, eligibility criteria, or reported results.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0, indicating an update to the document set.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added and a prior government funding notice along with Revision: v3.4.1 were removed; these are system-level updates and do not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.